by Paul Krzyzanowski | Mar 9, 2011
Patenting report shows disconnect in Canada by Paul Krzyzanowski Got a patentable idea? You might want to move to Switzerland. A recent article in the Globe and Mail compared Canada’s patenting activity to other major countries, and the small European nation...
by Chris Kamel | Mar 2, 2011
They’re promising, but not perfect. Induced pluripotent stem cells are perhaps one of the most studied areas of stem cell research today, as researchers work to improve their method of production, but new findings out of Canada and Finland suggests that the...
by Chris Kamel | Feb 28, 2011
We’ve talked often about induced pluripotent stem cells (iPS cells) on this blog — the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages — mostly in the context of discoveries in mice...
by Michelle Ly | Feb 22, 2011
As we get further into 2011, embryonic stem (ES) cells continue to be a hot topic. The ability of ES cells to differentiate into virtually any other type of cell makes them a prime avenue for research in biomedical applications. They have also been a source of great...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
Comments